Cargando…

Application of Advanced Mass Spectrometry-Based Proteomics to Study Hypoxia Driven Cancer Progression

Cancer is one of the largest contributors to the burden of chronic disease in the world and is the second leading cause of death globally. It is associated with episodes of low-oxygen stress (hypoxia or ischemia/reperfusion) that promotes cancer progression and therapeutic resistance. Efforts have b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vinaiphat, Arada, Low, Jee Keem, Yeoh, Kheng Wei, Chng, Wee Joo, Sze, Siu Kwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940826/ https://www.ncbi.nlm.nih.gov/pubmed/33708620 http://dx.doi.org/10.3389/fonc.2021.559822

Ejemplares similares

Microenvironmental Hypoxia Induces Dynamic Changes in Lung Cancer Synthesis and Secretion of Extracellular Vesicles
por: Tse, Shun Wilford, et al.
Publicado: (2020)

Discrimination of urinary exosomes from microvesicles by lipidomics using thin layer liquid chromatography (TLC) coupled with MALDI-TOF mass spectrometry
por: Singhto, Nilubon, et al.
Publicado: (2019)

Retraction Note: Discrimination of urinary exosomes from microvesicles by lipidomics using thin layer liquid chromatography (TLC) coupled with MALDI-TOF mass spectrometry
por: Singhto, Nilubon, et al.
Publicado: (2022)

Pulsed SILAC-based proteomic analysis unveils hypoxia- and serum starvation-induced de novo protein synthesis with PHD finger protein 14 (PHF14) as a hypoxia sensitive epigenetic regulator in cell cycle progression
por: Park, Jung Eun, et al.
Publicado: (2019)

More complete polarization of renal tubular epithelial cells by artificial urine
por: Vinaiphat, Arada, et al.
Publicado: (2018)

ERO1α promotes hypoxic tumor progression and is associated with poor prognosis in pancreatic cancer
por: Gupta, Nikhil, et al.
Publicado: (2019)

Quantitative Mass Spectrometry-Based Proteomic Profiling for Precision Medicine in Prostate Cancer
por: Flores-Morales, Amilcar, et al.
Publicado: (2017)

Alpha-tubulin enhanced renal tubular cell proliferation and tissue repair but reduced cell death and cell-crystal adhesion
por: Manissorn, Juthatip, et al.
Publicado: (2016)

Molecular Markers of MDR of Chemotherapy for HSCC: Proteomic Screening With High-Throughput Liquid Chromatography-Tandem Mass Spectrometry
por: Shen, Bin, et al.
Publicado: (2021)

Towards unravelling biological mechanisms behind radiation-induced oral mucositis via mass spectrometry-based proteomics
por: Subedi, Prabal, et al.
Publicado: (2023)

Hypoxia-driven ncRNAs in breast cancer
por: H. Al-Zuaini, Hashim, et al.
Publicado: (2023)

Artificially intelligent proteomics improves cardiovascular risk assessment
por: Sze, Siu Kwan
Publicado: (2019)

Application of Mass Spectrometry in Pancreatic Cancer Translational Research
por: Ge, Peng, et al.
Publicado: (2021)

Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report
por: Murray, David L., et al.
Publicado: (2021)

Mass spectrometry for translational proteomics: progress and clinical implications
por: Baker, Erin Shammel, et al.
Publicado: (2012)

Fibrillary Glomerulonephritis and Monoclonal Gammopathy: Potential Diagnostic Challenges
por: Da, Yi, et al.
Publicado: (2022)

Hypoxia-Induced Degenerative Protein Modifications Associated with Aging and Age-Associated Disorders
por: Adav, Sunil S, et al.
Publicado: (2020)

Immunoglobulin M Monoclonal Gammopathies of Clinical Significance
por: Girard, Louis-Pierre, et al.
Publicado: (2022)

Proteome discovery pipeline for mass spectrometry-based proteomics
por: Gough, Erik, et al.
Publicado: (2008)

mspire: mass spectrometry proteomics in Ruby
por: Prince, John T., et al.
Publicado: (2008)

Computational Mass Spectrometry–Based Proteomics
por: Käll, Lukas, et al.
Publicado: (2011)

Comparing cellular proteomes by mass spectrometry
por: Fröhlich, Florian, et al.
Publicado: (2009)

Urine Proteomics in the Era of Mass Spectrometry
por: Beasley-Green, Ashley
Publicado: (2016)

Use of Mass Spectrometry to Screen Glycan Early Markers in Hepatocellular Carcinoma
por: de Oliveira, Raphaela Menezes, et al.
Publicado: (2018)

Quantitative SWATH-Based Proteomic Profiling for Identification of Mechanism-Driven Diagnostic Biomarkers Conferring in the Progression of Metastatic Prostate Cancer
por: Singh, Anshika N., et al.
Publicado: (2020)

Proteomic Analysis and Discovery Using Affinity Proteomics and Mass Spectrometry
por: Olsson, Niclas, et al.
Publicado: (2011)

Insight of brain degenerative protein modifications in the pathology of neurodegeneration and dementia by proteomic profiling
por: Adav, Sunil S., et al.
Publicado: (2016)

Critical role of mass spectrometry proteomics in tear biomarker discovery for multifactorial ocular diseases (Review)
por: Ma, Jessica Yuen Wuen, et al.
Publicado: (2021)

Proteomics and Mass Spectrometry for Cancer Biomarker Discovery
por: Lu, Ming, et al.
Publicado: (2007)

Mass spectrometry–based proteomics in cell biology
por: Walther, Tobias C., et al.
Publicado: (2010)

Proteomics and mass spectrometry in the diagnosis of renal amyloidosis
por: Picken, Maria M.
Publicado: (2015)

Web Resources for Mass Spectrometry-based Proteomics
por: Chen, Tao, et al.
Publicado: (2015)

Heart Disease, Clinical Proteomics and Mass Spectrometry
por: Stanley, Brian A., et al.
Publicado: (2004)

Mass spectrometry-based draft of the mouse proteome
por: Giansanti, Piero, et al.
Publicado: (2022)

Beyond mass spectrometry, the next step in proteomics
por: Timp, Winston, et al.
Publicado: (2020)

Emergence of mass spectrometry detergents for membrane proteomics
por: Behnke, Jan-Simon, et al.
Publicado: (2023)

Characterizing citrullination by mass spectrometry-based proteomics
por: Rebak, A. S., et al.
Publicado: (2023)

Data-independent acquisition mass spectrometry identification of extracellular vesicle biomarkers for gastric adenocarcinoma
por: Gu, Lei, et al.
Publicado: (2022)

Hypoxia Activated EGFR Signaling Induces Epithelial to Mesenchymal Transition (EMT)
por: Misra, Ashish, et al.
Publicado: (2012)

Novel Prognostic Markers in Triple-Negative Breast Cancer Discovered by MALDI-Mass Spectrometry Imaging
por: Phillips, Leo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e7n9n85m23grph5aqou0moeoab